Skip to main content

Health condition

CARASIL and small vessel genetics

Beyond CADASIL lies a widening family of genetic small vessel diseases - CARASIL, COL4A1/A2, HTRA1-related and others - worth knowing when strokes and white matter disease appear young or run in families.

Key points

What matters most, at a glance.

The essentials in plain English - symptoms, when to seek help, who to see and what treatment looks like.

  • CARASIL (recessive HTRA1) combines early small vessel disease with back problems and hair loss; heterozygous HTRA1 variants cause a milder dominant form

  • COL4A1/A2 disorders cause brain haemorrhage, porencephaly and eye and kidney features across generations

  • Fabry disease, mitochondrial disease and retinal vasculopathies (RVCL) also masquerade as young small vessel disease

  • Consider genetics when white matter disease or lacunar strokes occur under 55, without hypertension, or with a family pattern

  • Panel testing covering the known genes is available through neurogenetics services

  • A genetic label changes surveillance, family advice and sometimes treatment (notably in Fabry)

Understanding it

About CARASIL and small vessel genetics, and what to do next.

Sporadic small vessel disease is overwhelmingly a disease of age, blood pressure and smoking - so when scans show it in a 40-year-old with none of those, or several relatives share early strokes and cognitive decline, the genetic differential earns attention. Alongside CADASIL sit rarer siblings: CARASIL and dominant HTRA1 disease; COL4A1/A2 collagenopathies, where fragile vessels bleed and family histories include infantile porencephaly, cataracts and kidney cysts; retinal vasculopathy with cerebral leukoencephalopathy (TREX1); and the metabolic mimics - Fabry disease and mitochondrial cytopathies - that come with their own treatments and surveillance.

The practical value of naming the gene is concrete: COL4A1 families need imaging before anticoagulation decisions and counselling around pregnancy and contact sports; Fabry unlocks enzyme or chaperone therapy; RVCL redirects prognosis entirely; and every dominant diagnosis opens informed cascade testing to relatives. Referral routes run through neurology to neurogenetics, where panels covering the recognised genes are interpreted with the phenotype in hand - important, because variants of uncertain significance are common in these genes and need expertise rather than alarm. Young-onset unexplained small vessel disease is a legitimate reason to ask directly about genetic assessment.

A quiet reminder

This guide is for information, not medical advice.

Your GP knows your history and can tell you which parts apply to you. If in doubt, see them.

Frequently asked

Common questions about CARASIL and small vessel genetics.

Quick, plain-English answers to what people ask us most.

  • What is CARASIL and small vessel genetics?

    CARASIL and small vessel genetics is a recognised medical condition that can affect people in different ways, ranging from mild and easily managed to more significant, depending on the underlying cause, how early it is picked up, and how it is treated. Getting a clear diagnosis is usually the first step towards the right management plan.

  • What causes CARASIL and small vessel genetics?

    CARASIL and small vessel genetics can arise from a combination of factors, which may include genetics, lifestyle, environmental exposures, other underlying health conditions, or simply the normal effects of ageing on the body. In many cases no single cause is found, and several factors act together. A clinician can help identify which factors are most relevant in an individual case.

  • What are the symptoms of CARASIL and small vessel genetics?

    Symptoms of CARASIL and small vessel genetics vary from person to person and depend on how severe the condition is and which structures are affected. Some people notice symptoms gradually over weeks or months, while others experience a more sudden onset. Because symptoms can overlap with other conditions, a proper assessment is important to reach an accurate diagnosis rather than relying on symptoms alone.

  • Is CARASIL and small vessel genetics serious or dangerous?

    Most cases of CARASIL and small vessel genetics are manageable, especially when identified and treated early, but severity varies from mild and self-limiting to more significant, depending on individual circumstances. Left unassessed, some cases can lead to complications or a longer-term impact on daily life. If you are worried about your symptoms, it is always worth getting them checked rather than waiting.

  • Is CARASIL and small vessel genetics hereditary or genetic?

    Some cases of CARASIL and small vessel genetics have a genetic component and can run in families, while others occur without any family history at all. Having a relative with the condition may modestly increase your own risk, but it does not mean you will definitely develop it yourself. If you are concerned about a family history, mention this to your doctor, as it may occasionally influence screening or monitoring.

  • Can CARASIL and small vessel genetics be cured, reversed or prevented?

    Outlook varies with CARASIL and small vessel genetics: some cases resolve completely with treatment, others improve significantly but need ongoing management, and a smaller number become a long-term condition to be controlled rather than cured. Prevention strategies, such as addressing modifiable risk factors, can reduce your chances of developing it or of it recurring, but cannot guarantee against it in every case.

  • How is CARASIL and small vessel genetics treated?

    Treatment for CARASIL and small vessel genetics is tailored to the individual and depends on severity, underlying cause and personal circumstances. Options can range from simple lifestyle measures, monitoring and conservative treatment through to medication, specialist procedures or surgery in more significant cases. A specialist assessment helps identify which combination of treatments is most appropriate for you.

  • How long does CARASIL and small vessel genetics last?

    The duration of CARASIL and small vessel genetics varies considerably: some people recover within days or weeks, while others live with a more persistent or recurring condition that needs ongoing management. Response to treatment, how early it is started, and individual factors all influence the timescale. Your clinician can give you a more personalised estimate once your specific circumstances are known.

  • When is surgery needed for CARASIL and small vessel genetics?

    Surgery is not usually the first option for CARASIL and small vessel genetics and is generally reserved for cases where conservative treatment has not worked, symptoms are severe, or there is a significant structural problem that needs to be corrected directly. The decision depends on your specific findings, symptoms and how they are affecting your life. A specialist consultation is the best way to establish whether surgery is being considered too early, or should be considered sooner rather than later.

  • When should I see a doctor about CARASIL and small vessel genetics, and how quickly can I be seen privately?

    It is worth seeing a doctor about CARASIL and small vessel genetics if symptoms are persistent, getting worse, or affecting your daily life, rather than waiting to see if they settle on their own. NHS routine referrals to a specialist can currently take anywhere from around 20 to 45 weeks or more depending on your area, whereas a private consultant can typically see you within about 2 weeks. Getting an earlier assessment can help clarify the diagnosis and start the right treatment sooner.